Quest PharmaTech to start Phase II Oregovomab clinical trial

11:00 EDT 15 Jun 2012 | Pharmaceutical Business Review

Quest PharmaTech has got clearance from FDA to initiate US sites for an ongoing international Phase II clinical trial for oregovomab in advanced ovarian cancer patients.

Original Article: Quest PharmaTech to start Phase II Oregovomab clinical trial

More From BioPortfolio on "Quest PharmaTech to start Phase II Oregovomab clinical trial"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

Latest Biotechnology, Pharmaceutical and Healthcare News

Biobetters, drugs that have been improved since their initial incarnations, are demonstrating fantastic growth and leaving their originators well behind

Astellas set for more Vesomni approvals after Netherlands nod

BTG aims for billion dollar interventional business with double buy

Zensun eyes US Phase III start for first-in-class CHF drug

HealthEdge to Present “Adapting to a Changing Payer Marketplace: Insight and Advice from the Front Lines” at AHIP’s Institute 2013

Positive new data on Novartis' Galvus in elderly type 2 diabetes patients

Alexza deal with Teva sets stage for Adasuve, say analysts

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.